Egyptian International Pharmaceutical Industries Co. (PHAR) P/E Ratio
P/E Ratio
9.95
Trailing P/E (TTM earnings)
As of 23 Jul 2026, 19:29 (Cairo time)
The price-to-earnings (P/E) ratio divides the share price by earnings per share, showing how much investors pay for each pound of annual profit. It is a core valuation yardstick for comparing companies within an EGX sector.
Health Technology peers by P/E ratio
| Company | P/E ratio |
|---|---|
| Egyptian International Pharmaceutical Industries Co. (PHAR) | 9.95 |
| Memphis Pharmaceutical & Chemical Industries (MPCI) | 12.2 |
| Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA) | 28.07 |
| El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH) | 37.91 |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.